S. Blankenberg | Turku Hypertension Center

Latest

Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals with diabetes mellitus
Exploring the incremental utility of circulating biomarkers for robust risk prediction of incident atrial fibrillation in European cohorts using regressions and modern machine learning methods
Risk prediction of atrial fibrillation and its complications in the community using hs troponin I
Risk Factors, Subsequent Disease Onset, and Prognostic Impact of Myocardial Infarction and Atrial Fibrillation
Diabetes status-related differences in risk factors and mediators of heart failure in the general population: results from the MORGAM/BiomarCaRE consortium
Age-specific atrial fibrillation incidence, attributable risk factors and risk of stroke and mortality: results from the MORGAM Consortium
Risk prediction of atrial fibrillation in the community combining biomarkers and genetics
Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort
Cardiac Troponin I and Incident Stroke in European Cohorts: Insights From the BiomarCaRE Project
Comparison of Cardiovascular Risk Factors in European Population Cohorts for Predicting Atrial Fibrillation and Heart Failure, Their Subsequent Onset, and Death
Temporal relations between atrial fibrillation and ischaemic stroke and their prognostic impact on mortality
Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium
NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and the Risk of Stroke
Sex-Specific Epidemiology of Heart Failure Risk and Mortality in Europe: Results From the BiomarCaRE Consortium
Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe)
Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium